Search

ViiV Healthcare premieres early data showing antiviral activity against integrase resistance from its investigational, third-generation integrase inhibitor

Media

Data, along with results from a phase I study, are the first public presentation of VH4524184.

https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-premieres-early-data-showing-antiviral-activity-against-integrase-resistance-from-its-investigational-third-generation-integrase-inhibitor/

First published: 23 July 2024

Antiviral activity of S/GSK1349572, the only once-daily, unboosted integrase inhibitor in clinical development, evaluated in phase 2 study

Media

GSK announced results from Phase 2a study evaluating antiviral activity of INI, S/GSK1349572, results presented at IAS Conference.

https://www.gsk.com/en-gb/media/press-releases/antiviral-activity-of-sgsk1349572-the-only-once-daily-unboosted-integrase-inhibitor-in-clinical-development-evaluated-in-phase-2-study/

First published: 20 July 2009

Antiviral Activity of S/GSK1265744, a Once-Daily, Unboosted Integrase Inhibitor in Clinical Development, Evaluated in Phase 1-2a Study in Healthy and HIV-Infected Subjects

Media

GSK announced results from Phase 1-2a study evaluating PK, safety and activity of its INI S/GSK1265744 in healthy HIV-infected patients.

https://www.gsk.com/en-gb/media/press-releases/antiviral-activity-of-sgsk1265744-a-once-daily-unboosted-integrase-inhibitor-in-clinical-development-evaluated-in-phase-1-2a-study-in-healthy-and-hiv-infected-subjects/

First published: 13 September 2009

ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV

Media

Data from the BANNER study show antiviral efficacy, safety, and tolerability of N6LS, supporting its continued study in phase IIb

https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-positive-proof-of-concept-findings-for-n6ls/

First published: 25 October 2022

Hiv Analyst Call Presentation

Media

https://www.gsk.com/media/8167/hiv-analyst-call-presentation.pdf

First published: 06 June 2022

Gold Man Sachs Seminar On Hic And Viiv Healtcare Presentation

Media

https://www.gsk.com/media/8180/gold-man-sachs-seminar-on-hic-and-viiv-healtcare-presentation.pdf

First published: 06 June 2022

Jpm 2017 Pv Presentation

Media

https://www.gsk.com/media/8170/jpm-2017-pv-presentation.pdf

First published: 06 June 2022

Fuelling Our Future Growth Slides

Media

https://www.gsk.com/media/8119/fuelling-our-future-growth-slides.pdf

First published: 01 June 2022

Gsk Hiv Event Transcript 29Nov21

Media

https://www.gsk.com/media/7974/gsk-hiv-event-transcript-29nov21.pdf

First published: 01 June 2022

Patrick Vallance Presentation Transcript

Media

https://www.gsk.com/media/8171/patrick-vallance-presentation-transcript.pdf

First published: 06 June 2022